| Code | 0525F | ||||||||||
| MA number | 70/0053/17-S | ||||||||||
| Product Form: | tbl 30x2 mg (fľ. HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Upjohn EESV, Netherland | ||||||||||
| Therapeutic Class: | 70 - ANXIOLYTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 08.12.1985 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_XANAX_12.2021.pdf
|
| PIL: |
PIL_XANAX_05.2024.pdf
|
| Safety feature | Yes |
| Data update: | 30.06.2025 |
